ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2607

Ultrasound Detection of Calcinosis and Correlation with Ulnar Artery Occlusion in Patients with Systemic Sclerosis

Robert Fairchild1, Melody Chung 1, Laurel Sharpless 1, Shufeng Li 2 and Lorinda Chung 1, 1Stanford University, Palo Alto, CA, 2Division of Immunology and Rheumatology, Department of Medicine, Stanford, Palo Alto, CA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: calcinosis, Scleroderma, Systemic sclerosis, ultrasonography and Doppler ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Sclerosis (SSc) is a progressive fibrotic and vascular disease affecting multiple organs. Calcinosis cutis in SSc is characterized by calcium deposition in the skin and subcutaneous tissues and can lead to significant morbidity.  While the pathophysiology of calcinosis in SSc is poorly understood, vascular ischemia is thought to play a role. Ultrasound (US) is well suited to vascular and soft tissue interrogation and may be helpful to detect, monitor, and study calcinosis in SSc. We sought to evaluate the ability of US to detect calcinosis in the hands and wrists of SSc patients versus X-ray identified calcinosis and to evaluate the relationship between ultrasound markers of pathologic perfusion and the presence of calcinosis.

Methods: Patients meeting 2013 ACR/EULAR classification criteria for SSc were prospectively evaluated for calcinosis in the hands and wrists by both X-ray and US. US was performed by submerging the hands and wrists in a water bath for evaluation of all surfaces. The presence or absence of calcinosis was recorded for each of 44 zones (22 left and 22 right) based on our previously published methods, and the sensitivity and specificity for calcinosis detection by US versus X-ray was determined. We also obtained bilateral US vascular measurements of ulnar artery occlusion (UAO) and finger pulp blood flow (FPBF) in the 3rd and 4th digits. For each hand, associations between markers of pathologic blood flow (UAO, FPBF, and a composite severity score of UAO and FPBF) and the presence of calcinosis were assessed using generalized estimating equations.

Results: 43 SSc patients (19 diffuse and 24 limited) were enrolled and 17 (39.5%) were found to have X-ray evidence of calcinosis in at least 1 hand (10 bilateral, 7 unilateral). US identified 13 patients with calcinosis (9 bilateral, 4 unilateral). Of the 748 zones evaluated, X-rays identified 72 zones (9.6%) with calcinosis while US showed 76 (10.2%). The sensitivity and specificity for US detection of calcinosis versus X-ray was 61% and 95% by zone, 78% and 98% by hand, and 76% and 100% by patient, respectively. UAO was seen in 13/43 (30%) and 12/43 (28%) of left and right hands, respectively, and FPBF was absent in 1 or both digits of the left and right hands in 21 (49%) and 19 (44%), respectively. We found a strong association between UAO and X-ray identified calcinosis (OR 8.08, 95% CI 2.45-26.60, p< 0.001). Both FPBF (OR 2.66, 95% CI 0.83-8.52, p=0.099) and the composite severity score (OR 3.23, 95% CI 0.96-10.92, p=0.059) failed to show a significant association with calcinosis.

Conclusion: In a cohort of SSc patients we developed a new method for ultrasound detection and quantification of calcinosis and found it to be sensitive, and highly specific versus X-ray. We also found a strong relationship between UAO, a marker of decreased peripheral perfusion, and X-ray identified calcinosis. This is the first study to evaluate the performance of ultrasound in the detection of calcinosis and provides further support for an association between vascular disease in SSc and the pathogenesis of calcinosis.

Systemic sclerosis patients with -A- X-ray findings of calcinosis, -B- ultrasound identified calcinosis [red arrowheads] in the longitudinal palmar aspect of the 2nd finger [blue outline = flexor tendon], -C1-C2- absent and normal FPBF respectively, and -D1-D2- UAO and no UAO, respectively. UAO = ulnar artery occlusion, FPBF = finger pulp blood flow, DIP = distal interphalangeal

TP = true positive, FP = false positive, TN = true negative, FN = false negative

US = ultrasound, OR = odds ratio by generalized estimating equations. UAO = ulnar artery occlusion, FPBF = finger pulp blood flow. *FPBF absent if one or both measurements per hand were absent.


Disclosure: R. Fairchild, None; M. Chung, None; L. Sharpless, None; S. Li, None; L. Chung, BMS, 6, 9, Boehrenger-Ingelheim, 5, Boehringer Ingelheim, 5, Boehringer-Ingelheim, 5, Bristol-Myers Squib, 5, Eicos, 5, 6, 9, Eicos Steering Committee, 5, Mitsubishi Tanabe, 5, Reata, 5, 6, Reata DSMB, 5, Reatta, 5.

To cite this abstract in AMA style:

Fairchild R, Chung M, Sharpless L, Li S, Chung L. Ultrasound Detection of Calcinosis and Correlation with Ulnar Artery Occlusion in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/ultrasound-detection-of-calcinosis-and-correlation-with-ulnar-artery-occlusion-in-patients-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-detection-of-calcinosis-and-correlation-with-ulnar-artery-occlusion-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology